Related Experiment Video

Updated: Jul 15, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Prevalence and management of chronotropic incompetence in heart failure

Peter H Brubaker1, Dalane W Kitzman

  • 1Departments of Health and Exercise Science, Section on Internal Medicine (Cardiology), Wake Forest University, Box 7628, Reynolda Station, Winston-Salem, NC 27109, USA. brubaker@wfu.edu

Current Cardiology Reports
|May 2, 2007
PubMed

Insights

Chronotropic incompetence (CI) significantly impacts heart failure patients, reducing exercise capacity. Further research is needed on interventions to improve chronotropic function in heart failure.

Area of Science:

  • Cardiology
  • Heart Failure Research

Background:

  • Chronotropic incompetence (CI) is recognized for its prognostic value in coronary artery disease.
  • Less attention has been focused on CI prevalence and impact in heart failure (HF) populations.
  • Reported CI prevalence in HF varies widely (25%-70%) due to inconsistent definitions and methodologies.

Purpose of the Study:

  • To highlight the significance of chronotropic incompetence in heart failure.
  • To discuss the impact of chronotropic impairment on HF patient outcomes.
  • To review potential therapeutic interventions for chronotropic dysfunction in HF.

Main Methods:

  • Literature review of studies on chronotropic incompetence in heart failure.
  • Analysis of reported prevalence rates and assessment methodologies.
  • Examination of the pathophysiological consequences and potential treatments.

Main Results:

  • Chronotropic impairment significantly contributes to cardiovascular, neuromuscular, pulmonary, and neurohormonal maladaptations in HF patients.
  • Inappropriate chronotropic response to exercise can reduce peak oxygen uptake by 15%-20%.
  • The exact prevalence and mechanisms of CI in HF require further clarification.

Conclusions:

  • Chronotropic impairment negatively affects physical function and quality of life in heart failure.
  • Therapeutic strategies like exercise training and rate-adaptive pacing show promise but need more investigation.
  • Standardized definitions and methodologies are crucial for accurate CI assessment in heart failure research.

More Related Videos

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.